Kolexia
Francois Eric Oncologie médicale
Francois Eric
Oncologie médicale
Centre Antoine Lacassagne
Nice, France
306 Activités
734 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs du rectum Adénocarcinome Métastase tumorale Carcinomes Carcinome épidermoïde Tumeurs de l'anus Tumeurs du pancréas Tumeurs de l'oesophage

Collaborateurs

Voir plus
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Bennouna-Louridi Jaafar
Bennouna-Louridi Jaafar
Hôpital Foch, Suresnes, France
Ghiringhelli Francois
Ghiringhelli Francois
Centre Georges-François Leclerc, Dijon, France

Industries

Voir plus
Pierre Fabre
15 collaboration(s)
Dernière en 2023
Amgen
8 collaboration(s)
Dernière en 2021
Servier
6 collaboration(s)
Dernière en 2022
Mylan Medical
6 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
SCARCE: A Non-comparative Randomized 2:1 Phase II Study of Docetaxel, Cisplatin, and 5-fluorouracil in Combination or Not With Atezolizumab in Patients With Metastatic or Unresectable Locally Advanced Squamous Cell Anal Carcinoma
Essai Clinique (Roche)   08 mars 2024
Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   08 février 2024
INTERACT-ION: Ezabenlimab (BI 754091) and mDCF (Docetaxel, Cisplatin and 5-fluorouracil) Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma. A Phase II Study
Essai Clinique (Boehringer Ingelheim)   21 décembre 2023
Dorsal root ganglion stimulator-A targeted therapy for post-herpetic neuralgia: The Middle East Experience.
Pain practice : the official journal of World Institute of Pain   05 décembre 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 novembre 2023
NACRE: A Phase III Study Evaluating Two Neoadjuvant Treatments Radiochemotherapy (5 Weeks - 50Gy+Capecitabine) and Radiotherapy (1week - 25Gy) in Patient Over 75 With Locally Advanced Rectal Carcinoma
Essai Clinique (Unicancer)   12 octobre 2023
651P DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: A multicenter propensity score matching study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Prognostic impact of post-treatment FDG PET/CT in anal canal cancer: A prospective study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   09 septembre 2023
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
JAMA network open   05 septembre 2023
Néofirinox: Randomized Phase III Study Comparing Preoperative Chemoradiotherapy Alone Versus Neoadjuvant Chemotherapy With Folfirinox Regimen Followed by Preoperative Chemoradiotherapy for Patients With Resectable Locally Advanced Rectal Cancer
Essai Clinique (Unicancer)   30 août 2023